BSE filing, NSE: NATCAPSUQ. Summary written from the filing by ALFA Finder's alert engine.
Natural Capsules Ltd: key numbers
- Share price
- ₹138.79
- Market cap
- ₹144.5 Cr
- Revenue (annual)
- ₹187.2 Cr
- Net profit (annual)
- ₹-24.66 Cr
- P/E (TTM)
- -6.7×Sector 43.0×
- Promoter holding
- 50.92%+0.00% QoQ
- FII holding
- 0.08%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Natural Capsules Ltd
All →Natural Capsules Board Meeting Date
Natural Capsules Limited has given prior intimation of a board meeting on 13 Nov 2026 to consider unaudited standalone and consolidated quarterly financial results for the period ended September 2026. The trading window closes from 01 Oct 2026 to 15 Nov 2026.
Natural Capsules Preferential Issue
Natural Capsules clarifies the object of its ₹10.01 Crore preferential issue of shares and warrants. Proceeds fund working capital and capital expansion.
- Value
- ₹10.01 Cr
Natural Capsules Annual General Meeting
Natural Capsules Ltd dispatched a corrigendum to its upcoming EGM notice, revising the issue price and quantity for the proposed preferential allotment of shares and warrants.
Natural Capsules Fund Raise of ₹10.01 Cr
Natural Capsules Limited approved a revised preferential issue of 1,12,500 equity shares and 4,50,000 convertible warrants. The total aggregate fund raise is valued at Rs. 10.01 Crore.
- Value
- ₹10.01 Cr
Natural Capsules Board Meeting Date
Natural Capsules Limited is holding a board meeting at shorter notice on September 02, 2026, to revise the issue price and quantity for its proposed preferential issue.
Natural Capsules Annual General Meeting
Natural Capsules Limited has issued a notice for an EGM to approve a Rs. 10.00 Crore preferential allotment of equity shares and warrants to a promoter.
- Value
- ₹10.00 Cr
Other other announcement announcements
All →Sustainable Energy Infra Trust Other Announcement
Sustainable Energy Infra Trust says its RTA, KFin Technologies, moves its corporate office from December 1, 2026. Correspondence should now go to the new Kokapet address.
Kingfa Science & Technology (India) Other Announcement
Kingfa filed CARE Ratings' monitoring report on its Rs.500 crore preferential issue proceeds. Nil deviation from issue objects was reported for the quarter ended September 30, 2026.
Stallion India Fluorochemicals Other Announcement
Stallion India Fluorochemicals cancelled its analyst/investor meeting scheduled for 6 November 2026. The virtual meeting carried no financial or business event.
Tamilnad Mercantile Bank Other Announcement
Tamilnad Mercantile Bank revised its MCLR rates effective November 7, 2026. The one-year MCLR rises from 9.35% to 9.45%.
Vivid Electromech Other Announcement
Vivid Electromech filed IPO proceeds utilisation reports for the quarter ended September 30, 2026. Cumulative utilisation stood at Rs 81.64 Crore.
Molbio Diagnostics Other Announcement
Molbio Diagnostics filed CRISIL's monitoring agency report on IPO proceeds utilisation for the quarter ended 30 September 2026. The report states no deviation from the issue objects.